Opioid withdrawal syndrome-associated cognitive impairment: A narrative review.

BACKGROUND AND OBJECTIVES: Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS. This paper explores accumulating literature describing Opioid Withdrawal Syndrome-associated Cognitive Impairment (OWSCI) which may inform clinical care and therapeutics research. METHODS: A search of studies published before August 2026 was conducted via PubMed and Google Scholar (309 and 626 papers screened) via crossing "cognition" with "opioid withdrawal," "early opioid abstinence," "opioid use," or "opioid addiction." Bibliography searches were also conducted of core target papers defined as human adult studies measuring cognition during OWS from 1 to 15 days after last opioid use. RESULTS: Only seven studies were identified meeting core criteria. These varied considerably by design, patient samples, comorbidities, timing and methods of cognitive testing, and OWS treatments. The evidence thus far suggests OWSCI is a measurable transient feature of OWS that overlays, and is modulated by, a wide range of clinical variables including opioid history, medication treatments, other addictions, and neuropsychiatric comorbidities. DISCUSSION AND CONCLUSIONS: Future studies on OWSCI entailing more rigorous experimental controls and standardizations, while accounting for diverse comorbidities and OWS treatments, are needed to more fully characterize OWSCI. SCIENTIFIC SIGNIFICANCE: Growing data on OWSCI are deepening our understanding of neurobiological and clinical dimensions of OWS, potentially providing clues for improving treatments for patients transitioning through OWS into opioid-free recoveries.